Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-08-12

Clinical Trial Update: Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study

View source ↗

Summary

A completed clinical trial examining disturbances in the kynurenine pathway of tryptophan metabolism in schizophrenia, using quantitative RT-PCR to measure gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia | Status: COMPLETED